As reviewed above, TRPV4 can possibly potentiate invasion of breast cancer cells through Ca2+-dependent activation of AKT that leads to changes in actin dynamics and downregulation of junctional E-cadherin [240,241]. The gene discussed is AKT1; the disease is breast cancer.